Search

Your search keyword '"Theophylline administration & dosage"' showing total 3,083 results

Search Constraints

Start Over You searched for: Descriptor "Theophylline administration & dosage" Remove constraint Descriptor: "Theophylline administration & dosage"
3,083 results on '"Theophylline administration & dosage"'

Search Results

1. Harnessing chemical functionality of xylan hemicellulose towards carbohydrate polymer-based pH/magnetic dual-responsive nanocomposite hydrogel for drug delivery.

2. Tuning bio-aerogel properties. Part 3: Exploring silica-pectin composite aerogels for drug delivery.

3. Paraxanthine provides greater improvement in cognitive function than caffeine after performing a 10-km run.

4. Influence of design parameters on sustained drug release properties of 3D-printed theophylline tablets.

5. Effect of theophylline on serum and milk pharmacokinetics of tylosin following intramuscular administration in lactating goats.

6. Doxofylline as a steroid-sparing treatment in Mexican children with asthma.

7. Intranasal Theophylline: Potential Treatment for Long COVID Olfactory Dysfunction?

8. Role of Doxofylline, Low Dose Theophylline, and Dexamethasone in Mice (BALB/C) Model of Corticosteroid Resistant Asthma: A Comparative Study.

9. Genotoxic and mutagenic potential of 7-methylxanthine: an investigational drug molecule for the treatment of myopia.

10. An assessment of mutagenicity, genotoxicity, acute-, subacute and subchronic oral toxicity of paraxanthine (1,7-dimethylxanthine).

11. Injection-molded capsule bodies and caps based on polymer blends for controlled drug delivery.

12. Effect of histone acetylation on maintenance and reinstatement of morphine-induced conditioned place preference and ΔFosB expression in the nucleus accumbens and prefrontal cortex of male rats.

13. Lipotoxicity-associated inflammation is prevented by guarana ( Paullinia cupana ) in a model of hyperlipidemia.

14. Evaluation of Physiologically Based Pharmacokinetic Models to Predict the Absorption of BCS Class I Drugs in Different Pediatric Age Groups.

15. GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated.

16. Methylxanthines and Neurodegenerative Diseases: An Update.

17. Severe pallid breath-holding spells treated with low-dose theophylline.

18. Well-tempered MCMC simulations for population pharmacokinetic models.

19. Theophylline dosing and pharmacokinetics for renal protection in neonates with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia.

20. [Opioid-free general anesthesia and induced recovery from anesthesia in a patient with myotonic dystrophy type-1: a case report].

21. Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses.

22. Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach.

23. A novel natural GRAS-grade enteric coating for pharmaceutical and nutraceutical products.

24. Nonlinear mixed-effects models with misspecified random-effects distribution.

25. Theophylline Acetaldehyde as the Initial Product in Doxophylline Metabolism in Human Liver.

26. Preparation and characterization of a powder manufactured by spray drying milk based formulations for the delivery of theophylline for pediatric use.

27. Lung Health Care pilot project trims patient pill load and antibiotic prescription in primary health care settings in Kerala, India.

28. Extrapolation of Drug Clearance in Children ≤ 2 Years of Age from Empirical Models Using Data from Children (> 2 Years) and Adults.

29. A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study.

30. Investigations of the Influences of Processing Conditions on the Properties of Spray Dried Chitosan-Tripolyphosphate Particles loaded with Theophylline.

31. ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2 -/- Ovarian Cancer Cells.

32. Diaphragmatic recovery in rats with cervical spinal cord injury induced by a theophylline nanoconjugate: Challenges for clinical use.

33. Pharmacokinetics of a modified, compounded theophylline product in dogs.

34. Food-Drug Interaction between the Adlay Bran Oil and Drugs in Rats.

35. Esters of terpene alcohols as highly potent, reversible, and low toxic skin penetration enhancers.

36. Simultaneously Improving the Physicochemical Properties, Dissolution Performance, and Bioavailability of Apigenin and Daidzein by Co-Crystallization With Theophylline.

37. Efficacy of theophylline in patients with syncope without prodromes with normal heart and normal ECG.

38. Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets.

39. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.

40. Granisetron reduces the need for uterotonics but not sympathomimetics during cesarean delivery.

41. Physiologically-Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and Midazolam.

42. Serum theophylline after multiple dosing with transdermal gels in cats.

43. Feedforward and Feedback Control of a Pharmaceutical Coating Process.

44. Design of Inhalable Solid Dosage Forms of Budesonide and Theophylline for Pulmonary Combination Therapy.

45. Theophylline and Caffeine as Alternatives During an Aminophylline Shortage.

46. Exploratory studies in heat-assisted continuous twin-screw dry granulation: A novel alternative technique to conventional dry granulation.

47. Mechanical particle coating using ethylcellulose nanoparticle agglomerates for preparing controlled release fine particles; effect of coating temperature on coating performance.

48. Assessment of CYP-Mediated Drug Interactions for Evocalcet, a New Calcimimetic Agent, Based on In Vitro Investigations and a Cocktail Study in Humans.

49. Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery.

50. The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China.

Catalog

Books, media, physical & digital resources